Comparing the miRNA expression profile between fluorescence-activated cell sorted CD44+CD24−/low lineage BCSCs and the remaining non-tumorigenic human breast cancer cells, they found 37 miRNAs differentially expressed between non-tumorigenic cancer cells and BCSCs in eleven human breast cancer samples. This evidence concerns the gene CD44 and breast carcinoma.